First in (Wo)Man: Jessica J. Federer

Jessica Federer built her career inside the rooms where science, money, and power collide. As the first female Chief Digital Officer at Bayer, she helped steer a 120,000 person global company through the rise of digital medicine while confronting a harder truth: women were excluded from U.S. clinical trials until 1993. In this conversation, she explains how decades of “first in man” research shaped drug development, why women experience side effects at nearly 2x the rate of men, and how guidance on sex based differences did not arrive from the FDA until December 2025. She shares what it means to sit on a Yale Institutional Review Board, why clinical trial stipends over $3,000 get taxed, and why she believes participants deserve tax credits instead. From GLP 1 profits to $40,000,000 women’s health funds that barely move the needle, this episode names the gaps and the opportunity hiding inside them. RELATED LINKS Jessica Federer on LinkedIn Jessica Federer on Instagram Yale School of Public Health Health of Women Investor Summit FEEDBACK Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.com See Privacy Policy at and California Privacy Notice at .

You can listen to First in (Wo)Man: Jessica J. Federer online on Radio and Podcast. Open the player on this page to stream the available audio.

First in (Wo)Man: Jessica J. Federer is an episode from Out of Patients with Matthew Zachary by Matthew Zachary.

This episode is 00:41:35 long.

This episode was published on Mar 31, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Out of Patients with Matthew Zachary when more episodes are available from the podcast feed.